Back to search

Article

Fusion-derived phospho-neoepitopes define a prioritized candidate neoantigen repertoire in MASLD-HCC

2026-08-27

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> The rising burden of metabolic dysfunction-associated steatotic liver disease (MASLD)-associated hepatocellular carcinoma (HCC) underscores the need for innovative therapeutic strategies. <h4>Methods</h4> We integrated RNA-seq fusion detection, immunopeptidomics, and proteogenomics to systematically prioritize tumor-specific neoantigen candidates arising from gene fusions i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
06b1bb1e-6bd0-598f-a154-3f95e650eeeb
DOI
10.64898/2026.08.26.747243
Open publication

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Fusion-derived phospho-neoepitopes define a prioritized candidate neoantigen repertoire in MASLD-HCCDOI 10.64898/2026.08.26.747243
Select a neighboring publication to make it the new centre.